UPB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Upstream Bio, Inc.

NASDAQ | UPB

25.01

USD

$0.00

(

0.00%

)

At Close (As of Dec 2, 2025)

$1.26B

Market Cap

-

P/E Ratio

-6.4

EPS

$33.00

52 Week High

$5.14

52 Week Low

HEALTHCARE

Sector

UPB Chart

Recent Chart
Price Action

UPB Technicals

Tags:

UPB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.4M
Total Revenue $2.4M
Cost Of Revenue $89K
Costof Goods And Services Sold $89K
Operating Income -$78M
Selling General And Administrative $17M
Research And Development $63M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $12M
Interest Income $12M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $89K
Income Before Tax -$63M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$63M
Comprehensive Income Net Of Tax -
Ebit -$78M
Ebitda -$78M
Net Income -$63M

Revenue & Profitability

Earnings Performance

UPB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $482M
Total Current Assets $479M
Cash And Cash Equivalents At Carrying Value $326M
Cash And Short Term Investments $326M
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $2.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $145M
Other Current Assets $7.5M
Other Non Current Assets -
Total Liabilities $12M
Total Current Liabilities $11M
Current Accounts Payable $4M
Deferred Revenue -
Current Debt -
Short Term Debt $704K
Total Non Current Liabilities $1.1M
Capital Lease Obligations $1.8M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.8M
Other Current Liabilities $6M
Other Non Current Liabilities -
Total Shareholder Equity $470M
Treasury Stock -
Retained Earnings -$191M
Common Stock $53K
Common Stock Shares Outstanding $51M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$59M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $89K
Capital Expenditures $511K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$59M
Cashflow From Financing $419M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$63M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.4M
Total Revenue $2.4M
Cost Of Revenue $89K
Costof Goods And Services Sold $89K
Operating Income -$78M
Selling General And Administrative $17M
Research And Development $63M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $12M
Interest Income $12M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $89K
Income Before Tax -$63M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$63M
Comprehensive Income Net Of Tax -
Ebit -$78M
Ebitda -$78M
Net Income -$63M

UPB News

UPB Profile

Upstream Bio, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Upstream Bio, Inc. is a clinical-stage biotechnology firm based in Waltham, Massachusetts, dedicated to the advancement of innovative therapies for inflammatory diseases, with a particular emphasis on severe respiratory disorders. The company leverages cutting-edge research and development to address unmet medical needs in this specialty area. With a robust pipeline of therapeutic candidates, Upstream Bio is poised to make significant contributions to the treatment landscape for patients struggling with complex inflammatory conditions.

LPTX
+368.57%
$2.05
PAVS
-40.29%
$0.03
VRAX
+58.18%
$0.62
IXHL
+17.01%
$0.46
IRBT
+68.20%
$3.28
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
NVDA
-1.07%
$179.51
ONDS
+11.26%
$8.97
TWOH
0.00%
$0.00
PLUG
+5.68%
$2.22
NIO
-4.97%
$4.78
RR
+18.53%
$4.22
IPG
-1.95%
$24.57
TSLA
+4.19%
$447.24
ASST
+0.96%
$1.04
BYND
-3.10%
$1.25
BITF
-0.08%
$3.09
AXDX
-61.36%
$0.03
INTC
+0.57%
$43.72
VALE
+3.63%
$13.35
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
QCLS
+38.16%
$4.67
PFE
+1.84%
$25.61
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
BBD
-2.31%
$3.58
DNN
+4.05%
$2.69
MRVL
+7.15%
$99.54
BMNR
+5.28%
$33.59
NFLX
-5.05%
$103.82
INHD
-8.22%
$0.13
SOND
-23.45%
$0.12
MARA
+4.70%
$12.47
ACHR
+8.43%
$8.29
BMNU
+9.94%
$8.07
CAN
+2.04%
$0.96
F
+1.15%
$13.11
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
BAC
+1.67%
$54.08
BTBT
+4.01%
$2.33
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
CLSK
+5.30%
$14.43
QBTS
+10.75%
$24.92
KVUE
+0.11%
$16.88
CIFR
+5.24%
$18.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RGTI
+9.08%
$26.05
RIG
-0.91%
$4.31
PLTD
-2.65%
$6.77
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
WULF
+0.40%
$14.27
AMZN
-0.76%
$232.63
RIVN
+2.64%
$17.68
GOOG
+0.28%
$316.02
GOOGL
+1.63%
$320.97
HOOD
+6.10%
$133.64
AMD
+0.76%
$216.88
ASBP
-10.81%
$0.08
CHR
-6.96%
$0.04
AFMD
-34.94%
$0.18
NOK
+1.05%
$6.25
MSFT
-1.57%
$482.27
ALIT
-2.91%
$2.16
IMRN
-10.91%
$1.55
CMG
-0.55%
$33.95
AG
+2.51%
$15.91
HBAN
+2.65%
$17.00
WBD
+0.16%
$24.57
M
-1.10%
$22.46
PMAX
+26.43%
$2.87
BMY
+5.65%
$50.98
PCG
-0.78%
$15.20
PYPL
-2.64%
$61.23
PSTG
-27.29%
$68.87
MSTR
+4.43%
$189.38
CMND
-12.73%
$0.11
HTOO
+15.71%
$4.05
BTG
+1.01%
$4.47
GTLB
-12.06%
$38.13
T
-0.64%
$25.35
CGC
+4.95%
$1.16
SNAP
+0.20%
$7.63
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
SMR
+6.53%
$20.14
MODV
-25.22%
$0.43
DVLT
-2.92%
$1.82
CCL
+0.73%
$26.03
GRAB
-0.85%
$5.21
RXRX
+8.10%
$4.67
YGMZ
-13.68%
$0.07
LPTX
+368.57%
$2.05
PAVS
-40.29%
$0.03
VRAX
+58.18%
$0.62
IXHL
+17.01%
$0.46
IRBT
+68.20%
$3.28
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
NVDA
-1.07%
$179.51
ONDS
+11.26%
$8.97
TWOH
0.00%
$0.00
PLUG
+5.68%
$2.22
NIO
-4.97%
$4.78
RR
+18.53%
$4.22
IPG
-1.95%
$24.57
TSLA
+4.19%
$447.24
ASST
+0.96%
$1.04
BYND
-3.10%
$1.25
BITF
-0.08%
$3.09
AXDX
-61.36%
$0.03
INTC
+0.57%
$43.72
VALE
+3.63%
$13.35
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
QCLS
+38.16%
$4.67
PFE
+1.84%
$25.61
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
BBD
-2.31%
$3.58
DNN
+4.05%
$2.69
MRVL
+7.15%
$99.54
BMNR
+5.28%
$33.59
NFLX
-5.05%
$103.82
INHD
-8.22%
$0.13
SOND
-23.45%
$0.12
MARA
+4.70%
$12.47
ACHR
+8.43%
$8.29
BMNU
+9.94%
$8.07
CAN
+2.04%
$0.96
F
+1.15%
$13.11
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
BAC
+1.67%
$54.08
BTBT
+4.01%
$2.33
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
CLSK
+5.30%
$14.43
QBTS
+10.75%
$24.92
KVUE
+0.11%
$16.88
CIFR
+5.24%
$18.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
RGTI
+9.08%
$26.05
RIG
-0.91%
$4.31
PLTD
-2.65%
$6.77
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
WULF
+0.40%
$14.27
AMZN
-0.76%
$232.63
RIVN
+2.64%
$17.68
GOOG
+0.28%
$316.02
GOOGL
+1.63%
$320.97
HOOD
+6.10%
$133.64
AMD
+0.76%
$216.88
ASBP
-10.81%
$0.08
CHR
-6.96%
$0.04
AFMD
-34.94%
$0.18
NOK
+1.05%
$6.25
MSFT
-1.57%
$482.27
ALIT
-2.91%
$2.16
IMRN
-10.91%
$1.55
CMG
-0.55%
$33.95
AG
+2.51%
$15.91
HBAN
+2.65%
$17.00
WBD
+0.16%
$24.57
M
-1.10%
$22.46
PMAX
+26.43%
$2.87
BMY
+5.65%
$50.98
PCG
-0.78%
$15.20
PYPL
-2.64%
$61.23
PSTG
-27.29%
$68.87
MSTR
+4.43%
$189.38
CMND
-12.73%
$0.11
HTOO
+15.71%
$4.05
BTG
+1.01%
$4.47
GTLB
-12.06%
$38.13
T
-0.64%
$25.35
CGC
+4.95%
$1.16
SNAP
+0.20%
$7.63
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
SMR
+6.53%
$20.14
MODV
-25.22%
$0.43
DVLT
-2.92%
$1.82
CCL
+0.73%
$26.03
GRAB
-0.85%
$5.21
RXRX
+8.10%
$4.67
YGMZ
-13.68%
$0.07
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.